Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 July 2021 | Story Ruan Bruwer | Photo UFS Photo Archive

Two athletes, both employees of the University of the Free State (UFS), are now giving back to the sport in administrative roles.

Kesa Molotsane and Louzanne Coetzee are making time in their work and training schedules to serve the sports in which they have represented their country – Molotsane in cross-country and Coetzee in the 1 500 m and 800 m T11 category for athletes with a disability.

Louzanne_web content
Louzanne Coetzee Photo: UFS Photo Archive 

Coetzee is again heading for the Paralympic Games in Tokyo. She is a nominee for the International Paralympic Committee Athletes’ Council. Six representatives will be chosen at the Paralympics.

Coetzee was recently elected to the South African Sports Confederation and Olympic Committee Athletes’ Commission. She is also an athlete representative of the South African Sports Association for Physically Disabled.

Molotsane was co-opted into the National Executive Committee of University Sport South Africa as an assessor. She is also the new vice-chairperson of the Athletics South Africa Athletes Commission.

Kesa Molotsane_content
Kesa Molotsane. Photo: Supplied

“My biggest dream is to enable athletes to dream big, and for their dreams to be recognised. I would like to see them enjoy their sport,” said Molotsane.

“I think I probably missed a lot of opportunities in my career due to a lack of funding, so I don’t want to see anyone face the same situation.”

Molotsane was also recently named as one of two ambassadors for the SPAR Grand Prix Series. 

According to Coetzee, a former member of the Student Representative Council at the UFS, she believes that it is important for a current sportsperson to contribute and give input in their sport. 

“I enjoy leadership, it is perhaps a gift of mine. Serving the sport in that capacity is not something that is too much of an effort or takes too much of my time. I enjoy contributing and to see something move in a direction.”

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept